New Feature: Fill out your Profile to share more about you. Learn more...
FDA Approves Enhertu for Unresectable or Metastatic HER2-Low BC

moderators
Posts: 6,970
FDA Approves Enhertu for Unresectable or Metastatic HER2-Low Breast Cancer
Aug 5, 2022
On Aug. 5, 2022, the U.S. Food and Drug Administration approved Enhertu to treat unresectable or metastatic HER2-low breast cancer. Read more...
0
Categories
Join Us on Zoom: Upcoming virtual meetups. Read more...
Give your account some personality! Add a profile photo.